学术探索
学术期刊
新闻热点
数据分析
智能评审
立即登录
Tyrosine kinase inhibitors: Rationale, mechanisms of action, and implications for drug resistance
被引:26
作者
:
Busse, D
论文数:
0
引用数:
0
h-index:
0
机构:
Vanderbilt Univ, Sch Med, Div Oncol, Dept Med, Nashville, TN 37232 USA
Busse, D
Yakes, FM
论文数:
0
引用数:
0
h-index:
0
机构:
Vanderbilt Univ, Sch Med, Div Oncol, Dept Med, Nashville, TN 37232 USA
Yakes, FM
Lenferink, AEG
论文数:
0
引用数:
0
h-index:
0
机构:
Vanderbilt Univ, Sch Med, Div Oncol, Dept Med, Nashville, TN 37232 USA
Lenferink, AEG
Arteaga, CL
论文数:
0
引用数:
0
h-index:
0
机构:
Vanderbilt Univ, Sch Med, Div Oncol, Dept Med, Nashville, TN 37232 USA
Arteaga, CL
机构
:
[1]
Vanderbilt Univ, Sch Med, Div Oncol, Dept Med, Nashville, TN 37232 USA
[2]
Vanderbilt Univ, Sch Med, Dept Cell Biol, Nashville, TN 37232 USA
[3]
Dept Vet Affairs Med Ctr, Nashville, TN 37212 USA
[4]
Vanderbilt Ingram Canc Ctr, Nashville, TN USA
来源
:
SEMINARS IN ONCOLOGY
|
2001年
/ 28卷
/ 05期
关键词
:
D O I
:
10.1053/sonc.2001.28550
中图分类号
:
R73 [肿瘤学];
学科分类号
:
100214 ;
摘要
:
引用
收藏
页码:47 / 55
页数:9
相关论文
共 45 条
[1]
ALIMANDI M, 1995, ONCOGENE, V10, P1813
[2]
The ErbB signaling network in embryogenesis and oncogenesis: Signal diversification through combinatorial ligand-receptor interactions
Alroy, I
论文数:
0
引用数:
0
h-index:
0
机构:
WEIZMANN INST SCI,DEPT MOL CELL BIOL,IL-76100 REHOVOT,ISRAEL
WEIZMANN INST SCI,DEPT MOL CELL BIOL,IL-76100 REHOVOT,ISRAEL
Alroy, I
论文数:
引用数:
h-index:
机构:
Yarden, Y
[J].
FEBS LETTERS,
1997,
410
(01)
: 83
-
86
[3]
Unliganded epidermal growth factor receptor dimerization induced by direct interaction of quinazolines with the ATP binding site
Arteaga, CL
论文数:
0
引用数:
0
h-index:
0
机构:
VANDERBILT UNIV,SCH MED,VANDERBILT CANC CTR,DEPT CELL BIOL,NASHVILLE,TN 37232
Arteaga, CL
Ramsey, TT
论文数:
0
引用数:
0
h-index:
0
机构:
VANDERBILT UNIV,SCH MED,VANDERBILT CANC CTR,DEPT CELL BIOL,NASHVILLE,TN 37232
Ramsey, TT
Shawver, LK
论文数:
0
引用数:
0
h-index:
0
机构:
VANDERBILT UNIV,SCH MED,VANDERBILT CANC CTR,DEPT CELL BIOL,NASHVILLE,TN 37232
Shawver, LK
Guyer, CA
论文数:
0
引用数:
0
h-index:
0
机构:
VANDERBILT UNIV,SCH MED,VANDERBILT CANC CTR,DEPT CELL BIOL,NASHVILLE,TN 37232
Guyer, CA
[J].
JOURNAL OF BIOLOGICAL CHEMISTRY,
1997,
272
(37)
: 23247
-
23254
[4]
ARTEAGA CL, 1994, CANCER RES, V54, P4703
[5]
ARTEAGA CL, IN PRESS SEMIN ONCOL
[6]
Baselga J, 1998, CANCER RES, V58, P2825
[7]
ONCOGENES AND THE STRATEGY OF GROWTH-FACTORS
BASERGA, R
论文数:
0
引用数:
0
h-index:
0
BASERGA, R
[J].
CELL,
1994,
79
(06)
: 927
-
930
[8]
BOS M, 1997, CLIN CANCER RES, V3, P2009
[9]
Reversible G1 arrest induced by inhibition of the epidermal growth factor receptor tyrosine kinase requires up-regulation of p27KIP1 independent of MAPK activity
Busse, D
论文数:
0
引用数:
0
h-index:
0
机构:
Vanderbilt Univ, Sch Med, Div Med Oncol, Dept Med, Nashville, TN 37232 USA
Busse, D
Doughty, RS
论文数:
0
引用数:
0
h-index:
0
机构:
Vanderbilt Univ, Sch Med, Div Med Oncol, Dept Med, Nashville, TN 37232 USA
Doughty, RS
Ramsey, TT
论文数:
0
引用数:
0
h-index:
0
机构:
Vanderbilt Univ, Sch Med, Div Med Oncol, Dept Med, Nashville, TN 37232 USA
Ramsey, TT
Russell, WE
论文数:
0
引用数:
0
h-index:
0
机构:
Vanderbilt Univ, Sch Med, Div Med Oncol, Dept Med, Nashville, TN 37232 USA
Russell, WE
Price, JO
论文数:
0
引用数:
0
h-index:
0
机构:
Vanderbilt Univ, Sch Med, Div Med Oncol, Dept Med, Nashville, TN 37232 USA
Price, JO
Flanagan, WM
论文数:
0
引用数:
0
h-index:
0
机构:
Vanderbilt Univ, Sch Med, Div Med Oncol, Dept Med, Nashville, TN 37232 USA
Flanagan, WM
Shawver, LK
论文数:
0
引用数:
0
h-index:
0
机构:
Vanderbilt Univ, Sch Med, Div Med Oncol, Dept Med, Nashville, TN 37232 USA
Shawver, LK
Arteaga, CL
论文数:
0
引用数:
0
h-index:
0
机构:
Vanderbilt Univ, Sch Med, Div Med Oncol, Dept Med, Nashville, TN 37232 USA
Arteaga, CL
[J].
JOURNAL OF BIOLOGICAL CHEMISTRY,
2000,
275
(10)
: 6987
-
6995
[10]
Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease
Cobleigh, MA
论文数:
0
引用数:
0
h-index:
0
机构:
Rush Presbyterian St Lukes Med Ctr, Chicago, IL 60612 USA
Cobleigh, MA
Vogel, CL
论文数:
0
引用数:
0
h-index:
0
机构:
Rush Presbyterian St Lukes Med Ctr, Chicago, IL 60612 USA
Vogel, CL
Tripathy, D
论文数:
0
引用数:
0
h-index:
0
机构:
Rush Presbyterian St Lukes Med Ctr, Chicago, IL 60612 USA
Tripathy, D
Robert, NJ
论文数:
0
引用数:
0
h-index:
0
机构:
Rush Presbyterian St Lukes Med Ctr, Chicago, IL 60612 USA
Robert, NJ
Scholl, S
论文数:
0
引用数:
0
h-index:
0
机构:
Rush Presbyterian St Lukes Med Ctr, Chicago, IL 60612 USA
Scholl, S
Fehrenbacher, L
论文数:
0
引用数:
0
h-index:
0
机构:
Rush Presbyterian St Lukes Med Ctr, Chicago, IL 60612 USA
Fehrenbacher, L
Wolter, JM
论文数:
0
引用数:
0
h-index:
0
机构:
Rush Presbyterian St Lukes Med Ctr, Chicago, IL 60612 USA
Wolter, JM
Paton, V
论文数:
0
引用数:
0
h-index:
0
机构:
Rush Presbyterian St Lukes Med Ctr, Chicago, IL 60612 USA
Paton, V
Shak, S
论文数:
0
引用数:
0
h-index:
0
机构:
Rush Presbyterian St Lukes Med Ctr, Chicago, IL 60612 USA
Shak, S
Lieberman, G
论文数:
0
引用数:
0
h-index:
0
机构:
Rush Presbyterian St Lukes Med Ctr, Chicago, IL 60612 USA
Lieberman, G
Slamon, DJ
论文数:
0
引用数:
0
h-index:
0
机构:
Rush Presbyterian St Lukes Med Ctr, Chicago, IL 60612 USA
Slamon, DJ
[J].
JOURNAL OF CLINICAL ONCOLOGY,
1999,
17
(09)
: 2639
-
2648
←
1
2
3
4
5
→
共 45 条
[1]
ALIMANDI M, 1995, ONCOGENE, V10, P1813
[2]
The ErbB signaling network in embryogenesis and oncogenesis: Signal diversification through combinatorial ligand-receptor interactions
Alroy, I
论文数:
0
引用数:
0
h-index:
0
机构:
WEIZMANN INST SCI,DEPT MOL CELL BIOL,IL-76100 REHOVOT,ISRAEL
WEIZMANN INST SCI,DEPT MOL CELL BIOL,IL-76100 REHOVOT,ISRAEL
Alroy, I
论文数:
引用数:
h-index:
机构:
Yarden, Y
[J].
FEBS LETTERS,
1997,
410
(01)
: 83
-
86
[3]
Unliganded epidermal growth factor receptor dimerization induced by direct interaction of quinazolines with the ATP binding site
Arteaga, CL
论文数:
0
引用数:
0
h-index:
0
机构:
VANDERBILT UNIV,SCH MED,VANDERBILT CANC CTR,DEPT CELL BIOL,NASHVILLE,TN 37232
Arteaga, CL
Ramsey, TT
论文数:
0
引用数:
0
h-index:
0
机构:
VANDERBILT UNIV,SCH MED,VANDERBILT CANC CTR,DEPT CELL BIOL,NASHVILLE,TN 37232
Ramsey, TT
Shawver, LK
论文数:
0
引用数:
0
h-index:
0
机构:
VANDERBILT UNIV,SCH MED,VANDERBILT CANC CTR,DEPT CELL BIOL,NASHVILLE,TN 37232
Shawver, LK
Guyer, CA
论文数:
0
引用数:
0
h-index:
0
机构:
VANDERBILT UNIV,SCH MED,VANDERBILT CANC CTR,DEPT CELL BIOL,NASHVILLE,TN 37232
Guyer, CA
[J].
JOURNAL OF BIOLOGICAL CHEMISTRY,
1997,
272
(37)
: 23247
-
23254
[4]
ARTEAGA CL, 1994, CANCER RES, V54, P4703
[5]
ARTEAGA CL, IN PRESS SEMIN ONCOL
[6]
Baselga J, 1998, CANCER RES, V58, P2825
[7]
ONCOGENES AND THE STRATEGY OF GROWTH-FACTORS
BASERGA, R
论文数:
0
引用数:
0
h-index:
0
BASERGA, R
[J].
CELL,
1994,
79
(06)
: 927
-
930
[8]
BOS M, 1997, CLIN CANCER RES, V3, P2009
[9]
Reversible G1 arrest induced by inhibition of the epidermal growth factor receptor tyrosine kinase requires up-regulation of p27KIP1 independent of MAPK activity
Busse, D
论文数:
0
引用数:
0
h-index:
0
机构:
Vanderbilt Univ, Sch Med, Div Med Oncol, Dept Med, Nashville, TN 37232 USA
Busse, D
Doughty, RS
论文数:
0
引用数:
0
h-index:
0
机构:
Vanderbilt Univ, Sch Med, Div Med Oncol, Dept Med, Nashville, TN 37232 USA
Doughty, RS
Ramsey, TT
论文数:
0
引用数:
0
h-index:
0
机构:
Vanderbilt Univ, Sch Med, Div Med Oncol, Dept Med, Nashville, TN 37232 USA
Ramsey, TT
Russell, WE
论文数:
0
引用数:
0
h-index:
0
机构:
Vanderbilt Univ, Sch Med, Div Med Oncol, Dept Med, Nashville, TN 37232 USA
Russell, WE
Price, JO
论文数:
0
引用数:
0
h-index:
0
机构:
Vanderbilt Univ, Sch Med, Div Med Oncol, Dept Med, Nashville, TN 37232 USA
Price, JO
Flanagan, WM
论文数:
0
引用数:
0
h-index:
0
机构:
Vanderbilt Univ, Sch Med, Div Med Oncol, Dept Med, Nashville, TN 37232 USA
Flanagan, WM
Shawver, LK
论文数:
0
引用数:
0
h-index:
0
机构:
Vanderbilt Univ, Sch Med, Div Med Oncol, Dept Med, Nashville, TN 37232 USA
Shawver, LK
Arteaga, CL
论文数:
0
引用数:
0
h-index:
0
机构:
Vanderbilt Univ, Sch Med, Div Med Oncol, Dept Med, Nashville, TN 37232 USA
Arteaga, CL
[J].
JOURNAL OF BIOLOGICAL CHEMISTRY,
2000,
275
(10)
: 6987
-
6995
[10]
Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease
Cobleigh, MA
论文数:
0
引用数:
0
h-index:
0
机构:
Rush Presbyterian St Lukes Med Ctr, Chicago, IL 60612 USA
Cobleigh, MA
Vogel, CL
论文数:
0
引用数:
0
h-index:
0
机构:
Rush Presbyterian St Lukes Med Ctr, Chicago, IL 60612 USA
Vogel, CL
Tripathy, D
论文数:
0
引用数:
0
h-index:
0
机构:
Rush Presbyterian St Lukes Med Ctr, Chicago, IL 60612 USA
Tripathy, D
Robert, NJ
论文数:
0
引用数:
0
h-index:
0
机构:
Rush Presbyterian St Lukes Med Ctr, Chicago, IL 60612 USA
Robert, NJ
Scholl, S
论文数:
0
引用数:
0
h-index:
0
机构:
Rush Presbyterian St Lukes Med Ctr, Chicago, IL 60612 USA
Scholl, S
Fehrenbacher, L
论文数:
0
引用数:
0
h-index:
0
机构:
Rush Presbyterian St Lukes Med Ctr, Chicago, IL 60612 USA
Fehrenbacher, L
Wolter, JM
论文数:
0
引用数:
0
h-index:
0
机构:
Rush Presbyterian St Lukes Med Ctr, Chicago, IL 60612 USA
Wolter, JM
Paton, V
论文数:
0
引用数:
0
h-index:
0
机构:
Rush Presbyterian St Lukes Med Ctr, Chicago, IL 60612 USA
Paton, V
Shak, S
论文数:
0
引用数:
0
h-index:
0
机构:
Rush Presbyterian St Lukes Med Ctr, Chicago, IL 60612 USA
Shak, S
Lieberman, G
论文数:
0
引用数:
0
h-index:
0
机构:
Rush Presbyterian St Lukes Med Ctr, Chicago, IL 60612 USA
Lieberman, G
Slamon, DJ
论文数:
0
引用数:
0
h-index:
0
机构:
Rush Presbyterian St Lukes Med Ctr, Chicago, IL 60612 USA
Slamon, DJ
[J].
JOURNAL OF CLINICAL ONCOLOGY,
1999,
17
(09)
: 2639
-
2648
←
1
2
3
4
5
→